Full Text View
Tabular View
No Study Results Posted
Related Studies
Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
This study has been completed.
Study NCT00356915   Information provided by Barrier Therapeutics/ Stiefel, a GSK Company
First Received: July 25, 2006   Last Updated: April 10, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Onychomycosis of the Toenail
Additional conditions recognized in this trial
Onychomycosis
More general conditions related to this trial
Dermatomycoses
Infection
Mycoses
Nail Diseases
Skin Diseases
Skin Diseases, Infectious
Tinea
Interventions listed in this trial
Itraconazole
Additional drug interventions recognized in this trial
Hydroxyitraconazole
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Barrier Therapeutics/ Stiefel, a GSK Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services